vs
MediWound Ltd.（MDWD）与Rithm Property Trust Inc.（RPT）财务数据对比。点击上方公司名可切换其他公司
MediWound Ltd.的季度营收约是Rithm Property Trust Inc.的1.7倍（$5.7M vs $3.4M），Rithm Property Trust Inc.净利率更高（95.4% vs -233.3%，领先328.7%），MediWound Ltd.同比增速更快（12.7% vs -39.7%）
MediWound Ltd.是一家聚焦烧伤护理、慢性创面治疗及软组织修复领域的生物制药企业，研发、生产及销售创新创面护理产品，主要面向北美、欧洲及亚洲市场的医院、医疗机构及患者提供服务。
Rithm Property Trust Inc.旗下的里思资本是一家总部位于纽约的美国投资管理公司，核心业务聚焦于房地产投资及另类投资领域，是该赛道颇具影响力的专业投资机构。
MDWD vs RPT — 直观对比
营收规模更大
MDWD
是对方的1.7倍
$3.4M
营收增速更快
MDWD
高出52.4%
-39.7%
净利率更高
RPT
高出328.7%
-233.3%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.7M | $3.4M |
| 净利润 | $-13.3M | $3.2M |
| 毛利率 | 23.5% | — |
| 营业利润率 | -100.1% | 99.6% |
| 净利率 | -233.3% | 95.4% |
| 营收同比 | 12.7% | -39.7% |
| 净利润同比 | -111.2% | 11.2% |
| 每股收益（稀释后） | $-1.23 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDWDRPT
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | $5.7M | $4.2M | ||
| Q1 25 | — | $249.0K | ||
| Q2 24 | $5.1M | — | ||
| Q3 23 | — | $1.1M | ||
| Q2 23 | $4.8M | — | ||
| Q1 23 | — | $540.0K |
净利润MDWDRPT
| Q4 25 | — | $3.2M | ||
| Q3 25 | — | $-273.0K | ||
| Q2 25 | $-13.3M | $1.9M | ||
| Q1 25 | — | $-3.4M | ||
| Q2 24 | $-6.3M | — | ||
| Q3 23 | — | $-5.5M | ||
| Q2 23 | $916.0K | — | ||
| Q1 23 | — | $-7.4M |
毛利率MDWDRPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 8.8% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 23.8% | — | ||
| Q1 23 | — | — |
营业利润率MDWDRPT
| Q4 25 | — | 99.6% | ||
| Q3 25 | — | -6.2% | ||
| Q2 25 | -100.1% | 45.7% | ||
| Q1 25 | — | -1416.5% | ||
| Q2 24 | -88.6% | — | ||
| Q3 23 | — | -533.4% | ||
| Q2 23 | -84.0% | — | ||
| Q1 23 | — | -1346.5% |
净利率MDWDRPT
| Q4 25 | — | 95.4% | ||
| Q3 25 | — | -6.8% | ||
| Q2 25 | -233.3% | 45.1% | ||
| Q1 25 | — | -1363.1% | ||
| Q2 24 | -124.5% | — | ||
| Q3 23 | — | -526.3% | ||
| Q2 23 | 19.2% | — | ||
| Q1 23 | — | -1369.3% |
每股收益（稀释后）MDWDRPT
| Q4 25 | — | $-0.26 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | $-1.23 | $0.01 | ||
| Q1 25 | — | $-0.08 | ||
| Q2 24 | $-0.68 | — | ||
| Q3 23 | — | $-0.25 | ||
| Q2 23 | $0.10 | — | ||
| Q1 23 | — | $-0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $79.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $20.1M | $291.6M |
| 总资产 | $67.0M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MDWDRPT
| Q4 25 | — | $79.3M | ||
| Q3 25 | — | $81.4M | ||
| Q2 25 | $1.1M | $98.6M | ||
| Q1 25 | — | $97.4M | ||
| Q2 24 | $3.8M | — | ||
| Q3 23 | — | $63.9M | ||
| Q2 23 | $19.2M | — | ||
| Q1 23 | — | $49.4M |
股东权益MDWDRPT
| Q4 25 | — | $291.6M | ||
| Q3 25 | — | $291.7M | ||
| Q2 25 | $20.1M | $294.7M | ||
| Q1 25 | — | $296.1M | ||
| Q2 24 | $17.9M | — | ||
| Q3 23 | — | $320.2M | ||
| Q2 23 | $34.9M | — | ||
| Q1 23 | — | $330.4M |
总资产MDWDRPT
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $67.0M | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q2 24 | $57.3M | — | ||
| Q3 23 | — | $1.4B | ||
| Q2 23 | $64.4M | — | ||
| Q1 23 | — | $1.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $-8.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -2.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDWDRPT
| Q4 25 | — | $-8.3M | ||
| Q3 25 | — | $-5.8M | ||
| Q2 25 | $-5.8M | $-25.0K | ||
| Q1 25 | — | $-1.6M | ||
| Q2 24 | $-3.6M | — | ||
| Q3 23 | — | $-10.7M | ||
| Q2 23 | $-5.3M | — | ||
| Q1 23 | — | $-16.8M |
资本支出强度MDWDRPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | 0.0% | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
现金转化率MDWDRPT
| Q4 25 | — | -2.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.01× | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -5.73× | — | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
